AI assistant
TherapeuticsMD, Inc. — Director's Dealing 2011
Oct 11, 2011
35134_dirs_2011-10-11_9ccb238f-37fa-413f-83f9-213a4827f211.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (AMHND)
CIK: 0000025743
Period of Report: 2011-10-04
Reporting Person: Krassan Mitchell (EVP, Chief Strategy Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified Stock Option | $0.1874 | 2020-05-01 | Common Stock (73646) | Direct | |
| Non-qualified Stock Option | $0.1874 | 2020-05-01 | Common Stock (92057) | Direct | |
| Non-qualified Stock Option | $0.2037 | 2020-09-01 | Common Stock (736455) | Direct |
Footnotes
F1: Option vests at the rate of 6,137 shares per month over the first year from the date of issuance. Shares vested to date are 73,646. This option was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.
F2: Option vests at the rate of 7,671 shares per month on the anniversary of the date of issuance. Shares vested to date are 92,057. This option was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.
F3: Option vests at the rate of 20,457 shares per month over the first three years from the date of issuance. Shares vested to date are 265,942. This option was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.